Literature DB >> 9631363

Malignancy associated changes in bronchial epithelial cells and clinical application as a biomarker.

N Ikeda1, C MacAulay, S Lam, J LeRiche, P Payne, D Garner, C Konaka, H Kato, B Palcic.   

Abstract

A total of 74 bronchial brushing specimens, 24 from patients with advanced stage cancer, eight from patients with CIS, 31 from patients with atypical metaplasia and 11 from normal subjects were examined for the existence of malignancy associated changes (MAC). Conventional fiberoptic bronchoscopy and fluorescence endoscopy was carried out on every case. Each case was classified according to the highest grade of abnormality diagnosed by bronchial biopsy of the suspect areas. During the endoscopy examination, a bronchial brushing specimen was obtained from a visually normal area very remote from the abnormal area as possible such as the opposite lung or another lobe. The bronchial brushing specimens were fixed, mounted and stained by a DNA specific method and approximately 1500 images of individual nuclei per case were captured by an automated high resolution image cytometry. For each of these images, more than 100 nuclear features such as size, shape and chromatin spatial organization were calculated. Discriminant function analysis revealed nuclear features which differentiated between normal bronchial cell nuclei from the normal subjects and ostensively normal nuclei (MAC cell nuclei) from the lung cancer patients. The best discrimination was achieved when the frequency of individual cells expressing MAC was 50% or greater. With this threshold, 75% of the patients with invasive cancer and CIS were correctly classified. Fifty percent of those with severe or moderate atypia and 35% with mild atypia were also MAC positive. The frequency of cells expressing MAC also increased as the degree of abnormality of the groups increased. MAC may be a useful criterium to determine biological behavior of the intra-epithelial (pre-invasive) neoplasia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9631363     DOI: 10.1016/s0169-5002(97)00095-0

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  5 in total

1.  Reconstruction of explicit structural properties at the nanoscale via spectroscopic microscopy.

Authors:  Lusik Cherkezyan; Di Zhang; Hariharan Subramanian; Allen Taflove; Vadim Backman
Journal:  J Biomed Opt       Date:  2016-02       Impact factor: 3.170

2.  Nanoscale refractive index fluctuations detected via sparse spectral microscopy.

Authors:  John E Chandler; Lusik Cherkezyan; Hariharan Subramanian; Vadim Backman
Journal:  Biomed Opt Express       Date:  2016-02-19       Impact factor: 3.732

3.  High-speed spectral nanocytology for early cancer screening.

Authors:  John E Chandler; Hariharan Subramanian; Charles D Maneval; Craig A White; Richard M Levenson; Vadim Backman
Journal:  J Biomed Opt       Date:  2013-11       Impact factor: 3.170

4.  Development of a nuclear morphometric signature for prostate cancer risk in negative biopsies.

Authors:  Peter H Gann; Ryan Deaton; Anup Amatya; Mahesh Mohnani; Erika Enk Rueter; Yirong Yang; Viju Ananthanarayanan
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

5.  Identification of Malignancy-Associated Changes in Histologically Normal Tumor-Adjacent Epithelium of Patients with HPV-Positive Oropharyngeal Cancer.

Authors:  James Jabalee; Anita Carraro; Tony Ng; Eitan Prisman; Cathie Garnis; Martial Guillaud
Journal:  Anal Cell Pathol (Amst)       Date:  2018-03-11       Impact factor: 2.916

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.